Lipocine Inc

Research Lipocine Inc (LPCN) on Bullrun: market cap USD 20.53M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLPCN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 20.53M
• Financial periodFY2025
• RevenueUSD 1.98M
• Revenue growth-82.3%
• Net income-USD 9.63M

Valuation Snapshot

latest market cap is USD 20.53M.

About Lipocine Inc

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate. It also develops LPCN 1154 (BRLIZIO), an oral neuro-steroid in a Phase 3 pivotal trial for postpartum depression;

Frequently asked questions

What is Lipocine Inc's market cap?

Lipocine Inc's market capitalization is USD 20.53M.

What does Lipocine Inc do?

Lipocine Inc., a clinical-stage biopharmaceutical company, engages in the research and development for the delivery of drugs using its proprietary delivery technology. The company offers TLANDO, an oral testosterone replacement therapy (TRT) comprising testosterone undecanoate.